Cargando…
TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF-7 cells
Tamoxifen is widely used as a highly effective drug for treating estrogen-receptor (ER) alpha-positive breast cancer. However, tamoxifen resistance developed during cancer treatment remains a significant challenge. Tongue cancer resistance-related protein1 (TCRP1), which is recognized as a novel dru...
Autores principales: | Zhao, Shuai, Li, Xiaohua, Yin, Lei, Hou, Lili, Lan, Jing, Zhu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160545/ https://www.ncbi.nlm.nih.gov/pubmed/32323833 http://dx.doi.org/10.3892/or.2020.7577 |
Ejemplares similares
-
TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1
por: Wang, C, et al.
Publicado: (2017) -
Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022) -
Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells
por: Nokhodi, Fariba, et al.
Publicado: (2022) -
Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)
por: Gu, Yixue, et al.
Publicado: (2017) -
TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a
por: Liu, Hao, et al.
Publicado: (2022)